<?xml version="1.0" encoding="UTF-8"?>
<p>Parkinson's disease (PD) and Alzheimer's disease (AD) are the two most common age-related neurodegenerative diseases. PD is primarily a movement disorder, the characteristic motor features of which mainly result from loss of dopaminergic neurons in the substantia nigra pars compacta [
 <xref rid="B1" ref-type="bibr">1</xref>]. However, patients with PD may experience a range of nonmotor symptoms, including some features commonly associated with AD, such as mild cognitive impairment that frequently progresses to dementia [
 <xref rid="B2" ref-type="bibr">2</xref>]. In addition to Lewy body pathology, typical AD related morphological changes, including amyloid-beta (A
 <italic>β</italic>) pathology, have been proposed to be involved in the pathogenesis of PD dementia. This is reinforced by neuroimaging studies using PET, and with the strong inverse association between A
 <italic>β</italic> load at autopsy and time to dementia in PD [
 <xref rid="B3" ref-type="bibr">3</xref>, 
 <xref rid="B4" ref-type="bibr">4</xref>].
</p>
